2008
DOI: 10.1002/jbm.b.31255
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of bone formation in hydroxyapatite implants by rhBMP‐2 coating

Abstract: The combination of hydroxyapatite (HA) implants serving as osteoconductive scaffold with growth factors is an interesting approach for the improvement of bone defect healing. The purpose of this study was to test whether recombinant human bone morphogenetic protein-2 (rhBMP-2) coating of solid HA-implants improves bone formation in a cortical bone defect. Cylindrical trephine mill defects (diameter: 9.8 mm, depth: 10 mm) were created into the cortical tibia shaft of minipigs and subsequently filled either by p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2010
2010
2013
2013

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 30 publications
(53 reference statements)
0
12
0
Order By: Relevance
“…The bone healing process is associated with the presence of osteoregenerative cells (osteoblastic cells), osteopromotive proteins (growth factors, like BMP‐2,4,6,7), and local environment (supplied by a material carrier) (Ripamonti, 2006). This study used rhBMP‐2, previously described in literature (Issa et al, 2008; Schnettler et al, 2009; Wang et al, 2009) as a protein presenting osteoinductive capability, and a protein extracted from Hevea brasiliensis (P‐1), which is currently being characterized. When the surgical area was covered with collagen, a higher amount of newly formed bone was found with the exception of Group IV with pure P‐1.…”
Section: Discussionmentioning
confidence: 99%
“…The bone healing process is associated with the presence of osteoregenerative cells (osteoblastic cells), osteopromotive proteins (growth factors, like BMP‐2,4,6,7), and local environment (supplied by a material carrier) (Ripamonti, 2006). This study used rhBMP‐2, previously described in literature (Issa et al, 2008; Schnettler et al, 2009; Wang et al, 2009) as a protein presenting osteoinductive capability, and a protein extracted from Hevea brasiliensis (P‐1), which is currently being characterized. When the surgical area was covered with collagen, a higher amount of newly formed bone was found with the exception of Group IV with pure P‐1.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast to healthy bone tissue which constantly adjusts its structure to varying environmental needs [6], these materials cannot be remodeled, often resulting in material fatigue, loosening and implant failure. Hence, an important characteristic of synthetic bone substitutes is their bioactivity, which should ideally allow a defined resorption that is balanced with the speed of new bone formation, resulting in true osseointegration and restitutio ad integrum [7], [8]. In this context it is important to state that so called “resorbable” bone substitutes, including calcium phosphates, calcium sulphates, and calcium carbonates, have been somewhat unsuccessful as they were still detectable years after implantation due to impaired resorption.…”
Section: Introductionmentioning
confidence: 99%
“…One of the strategies to enhance bone healing around implant, and therefore implant fixation and osseointegration, is to use the HA coating on the implant as a carrier for in situ delivering of drugs, such as bone morphogenetic proteins (BMP) 17. The incorporation of the drug during the process of the coating formation will ensure a sustained release of the drug into the surrounding bony tissue after the joint replacement surgery.…”
Section: Introductionmentioning
confidence: 99%